David F. Welch - 05 Sep 2021 Form 4 Insider Report for Infinera Corp

Role: Director
Signature: /s/ Michael Hopp, by Power of Attorney
Issuer symbol: N/A
Transactions as of: 05 Sep 2021
Net transactions value: -$27,395
Form type: 4
Filing time: 08 Sep 2021, 20:33:02 UTC
Previous filing: 08 Jun 2021
Next filing: 15 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INFN	Common Stock	Options Exercise	$0	+6,250	+0.93%	$0.000000	677,808	05 Sep 2021	See Footnote	F1
transaction	INFN	Common Stock	Tax liability	$27,395	-3,099	-0.46%	$8.84	674,709	05 Sep 2021	See Footnote	F1
holding	INFN	Common Stock						2,500	05 Sep 2021	See Footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INFN	Restricted Stock Units	Options Exercise	$0	-6,250	-14%	$0.000000	37,500	05 Sep 2021	Common Stock	43,750		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held directly by The Welch Family Trust U/A DTD 4/3/1996 ("The Welch Family Trust"), for which Dr. Welch is a trustee.
F2	Shares held directly by Dr. Welch as a trustee for his minor children. Dr. Welch disclaims beneficial ownership of the shares held in trust for his minor children, and this report shall not be deemed an admission that Dr. Welch is the beneficial owner of the shares held in trust for his minor children for purposes of Section 16 or for any other purpose.
F3	Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Infinera Corporation (the "Company").
F4	These RSUs vest as to one-third of the shares on the one year anniversary of the vesting commencement date, which is March 5, 2020, and 1/12th quarterly thereafter, subject to Dr. Welch's continued service to the Company through each applicable vesting date.